Frontlight ResearchEarly access
Trial site
Lombardi Comprehensive Cancer Center
- 4running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma3 trials
- Glioblastoma1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Thyroid cancer1 trial
- Phase
- Phase 23 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Georgetown University3 trials
- Hackensack Meridian Health2 trials
- Shuttle Pharmaceuticals, Inc.1 trial
- SkylineDx1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026